DM1-SMe - CAS 138148-68-2
Catalog number: B0238-477047
Category: ADCs
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C36H50ClN3O10S2
Molecular Weight:
784.38
COA:
Inquire
Tag:
ADCs Cytotoxin with Linkers
Description:
DM1-SMe is a potent maytansinoid microtubular inhibitor and an unconjugated DM1 as a mixed disulfide with thiomethane to cap its sulfhydryl group. DM1-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). .
Ordering Information
Catalog Number Size Price Stock Quantity
B0238-477047 25 mg $499 In stock
Bulk Inquiry
Purity:
≥98%
Appearance:
Soild powder
Synonyms:
DM1-SMe; DM1-SSMe; maytansinoid derivative with ADC linker. Maytansine or mertansine or emtansine derivative; N2'-deacetyl-N2'-[3-(methyldithio)-1-oxopropyl]maytansine.
MSDS:
Inquire
Canonical SMILES:
C[C@@H]1[C@@H]2C[C@](NC(O2)=O)(O)[C@H](OC)/C=C\C=C(C)\CC3=CC(N(C)C(C[C@@H](OC([C@@H](N(C(CCSSC)=O)C)C)=O)[C@@]4(C)C1O4)=O)=C(Cl)C(OC)=C3
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related ADCs Cytotoxin with Linkers Products


sulfo-SPDB-DM4

DM4 with a reactive linker sulfo-SPDB, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding...

CAS 1401963-15-2 Mc-MMAD

Mc-MMAD
(CAS: 1401963-15-2)

Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload in antibody drug conjugate; Mc-MMAD is a protective group (maleimidocaproyl) -con...

CAS 138148-68-2 DM1-SMe

DM1-SMe
(CAS: 138148-68-2)

DM1-SMe is a potent maytansinoid microtubular inhibitor and an unconjugated DM1 as a mixed disulfide with thiomethane to cap its sulfhydryl group. DM1-SMe can b...

CAS 646502-53-6 MC-Val-Cit-PAB-MMAE

MC-Val-Cit-PAB-MMAE
(CAS: 646502-53-6)

MC-Val-Cit-PAB-MMAE is a potent tubulin inhibitor (MMAE), Val-Cit-PAB-MMAE is an antibody drug conjugate.

Val-Cit-PAB-MMAE
(CAS: 644981-35-1)

Val-Cit-PAB-MMAE is a potent tubulin inhibitor (MMAE), Val-Cit-PAB-MMAE is an antibody drug conjugate.

Brentuximab vedotin
(CAS: 914088-09-8)

Brentuximab vedotin is an antibody-drug conjungate (ADC) used for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large ce...

DM4-SPDP

DM4 with a reactive linker SPDP, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site.

Fmoc-VC-PAB-MMAE
(CAS: 1350456-56-2)

Fmoc-Val-Cit-PAB-MMAE is an antibody drug conjugate contained Fmoc-Val-Cit-PAB and MMAE and probably have antineoplastic activity.

Chemical Structure

CAS 138148-68-2 DM1-SMe

Quick Inquiry

Verification code

Featured Items